Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Breast Neoplasms 11Prostatic Neoplasms 10Glioblastoma 10Oropharyngeal Neoplasms 7Rectal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Squamous Cell Carcinoma of Head and Neck 5Urinary Bladder Neoplasms 4Burkitt Lymphoma 4Adenocarcinoma of Lung 4Pancreatic Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Lymphoma, Follicular 3Hodgkin Disease 3Gliosarcoma 3Glioma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma 3Triple Negative Breast Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Neoplasm, Residual 2Mesothelioma, Malignant 2Meningeal Carcinomatosis 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

dinutuximab 2Vincristine 2Topotecan 2Thiotepa 2Stem Cell Transplantation 2Radiation 2Platinum 2Melphalan 2Isotretinoin 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2sargramostim 1Transurethral Resection of Bladder 1Temozolomide 1Specimen Handling 1Razoxane 1Radiotherapy 1Proton Therapy 1Nuclear Medicine Department, Hospital 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Irinotecan 1Hematopoietic Stem Cell Transplantation 1Dexrazoxane 1Congresses as Topic 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroblastoma × Radiotherapy × 30 days × Clear all
NCT06172296 2026-06-03

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Recruiting
478 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡